Expanding New Treatment Option to Frontline Treatment for Hodgkin Lymphoma
Dr. Steven Park from the UNC Lineberger Comprehensive Cancer Center, explains trials for the use of brentuximab vedotin (Adcetris) in the frontline... Learn More
Day
March 28, 2013